Home Overview Press Room Blog Publications For Students about us
Search

Inheritable Genetic Modification : Displaying 190-199 of 842


False Inevitabilities and Irrational Exuberanceby Gina Maranto, Biopolitical Times guest contributorJanuary 8th, 2016In the aftermath on December’s gene editing summit, disquieting themes have emerged in some mainstream media and science blogs.
Who is Smart Enough to Decide how to Improve the Human Species?by Joel AchenbachThe Washington PostJanuary 5th, 2016Genetic engineering and molecular biology benefit from the digital revolution. This convergence is arguably one of the biggest stories in the world right now.
King for a Day? On What’s Wrong With Changing the World for the Better by Roland NadlerLaw and Biosciences BlogJanuary 4th, 2016"It’s not so much about ethics (as we usually envision it) as about political philosophy. I’d exhort us to be quicker to ask: who died and made you king?"
Historic CRISPR Patent Fight Primed To Become Head-To-Head Battleby Alex LashXconomyJanuary 4th, 2016A USPTO patent examiner recommends kicking Jennifer Doudna's application upstairs. The case will be decided under the old "first to invent" standard.
A startup that wants to start using a controversial gene-editing tool in people by 2017 just filed to go publicby Lydia RamseyBusiness InsiderJanuary 4th, 2016Editas Medicine, co-founded by Feng Zhang, is developing a CRISPR gene therapy for rare blindness with human trials planned for 2017.
'We Won't Make Frankensteins,' Cloning Giant Boyalife's CEO Saysby David Lom and Eric BaculinaoNBC NewsDecember 26th, 2015The head of a Chinese firm that is building the world's biggest animal cloning factory has vowed not to use the technology on people — for now, at least.
First GMO Corn, then Frankenfish, and Now — Get Ready for Designer Babies[cites CGS' Marcy Darnovsky]by Janet PhelanActivist PostDecember 25th, 2015“The medical arguments are tenuous and the possible social consequences are grave” for modifying the human germline.
The Gene-Editing Tool on Every Drugmaker's Wish List This Yearby Caroline Chen and Doni BloomfieldBloombergDecember 23rd, 2015Complicating the race to apply CRISPR is a heated fight over who invented the approach and owns the right to use it, and how the industry will be regulated.
Biopolitical News of 2015by Elliot Hosman, Pete Shanks & Marcy Darnovsky, Biopolitical TimesDecember 22nd, 2015We highlight 2015’s breaking news stories about human biotech developments.
Bayer Forms Gene Editing Partnership with CRISPR Therapeuticsby Ludwig BurgerReutersDecember 21st, 2015Under the deal, the German drugmaker will pay for the joint venture's research over the next five years, 300 million euros in total.
Displaying 190-199 of 842  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760